Pemetrexed ditromethamine is the active pharmaceutical ingredient in a chemotherapy drug used mainly for treating certain types of cancer, including non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. It is a folate analog metabolic inhibitor, meaning it interferes with folate-dependent processes essential for cancer cell division and growth. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pemfexy and Alimta. Its PubChem CID is 135565228.
Pemetrexed ditromethamine
| CAS No | 1645228-03-0 |
|---|---|
| Molecular Formula | C28H43N7O12 |
| Molecular Weight | 669.7 g/mol |
| Synonyms | 2-amino-2-(hydroxymethyl)propane-1,3-diol;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pemetrexed ditromethamine is the active pharmaceutical ingredient in a chemotherapy drug used mainly for treating certain types of cancer, including non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma.
The listed CAS number is 1645228-03-0.
The listed molecular formula is C28H43N7O12.
The listed molecular weight is 669.7 g/mol.
2-amino-2-(hydroxymethyl)propane-1,3-diol;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid.
The source lists Pemfexy and Alimta.